Brief: Nordic Nanovector Q3 Comprehensive Loss Narrows To NOK 88.2 Million

Thor Medical ASA

19/11/2020 06:06

Nov 19 (Reuters) - Nordic Nanovector ASA  NORN.OL :
    * TOTAL OPERATING EXPENSES FOR Q3 WERE NOK 88.1 MILLION (NOK
100.2
MILLION)
    * COMPREHENSIVE LOSS FOR Q3 AMOUNTED TO NOK 88.2 MILLION
(LOSS OF
NOK 93.6 MILLION)
    * COMPANY CONTINUES TO TARGET READOUT OF THREE-MONTH TOP
LINE DATA
FROM PARADIGME IN H2'2021
    * COMPANY ALSO TARGETS READOUT OF THREE-MONTH TOP LINE DATA
FROM
SECOND COHORT OF ARCHER-1 TRIAL IN H1'2021.
    * COMPANY HAS TAKEN STEPS TO CONSERVE CASH AND FOLLOWING
RECENT
SUCCESSFUL PRIVATE PLACEMENT, NORDIC NANOVECTOR HAS A CASH
RUNWAY THAT EXTENDS INTO Q3'2021.
    * CASH AND CASH EQUIVALENTS AMOUNTED TO NOK 380.7 MILLION AT
END
OF SEPTEMBER 2020, COMPARED TO NOK 470.8 MILLION AT END OF
DECEMBER 2019

Source text for Eikon:  ID:nWkrVl5fP 
Further company coverage:  NORN.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))